New Zealand markets open in 3 hours 54 minutes

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
454.02-8.12 (-1.76%)
As of 01:06PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 119.28B
Enterprise value 114.42B
Trailing P/E 31.73
Forward P/E 25.91
PEG ratio (5-yr expected) 0.56
Price/sales (ttm)11.60
Price/book (mrq)8.07
Enterprise value/revenue 11.07
Enterprise value/EBITDA 246.01

Trading information

Stock price history

Beta (5Y monthly) 0.40
52-week change 330.13%
S&P500 52-week change 334.08%
52-week high 3510.64
52-week low 3341.90
50-day moving average 3478.22
200-day moving average 3444.32

Share statistics

Avg vol (3-month) 31.08M
Avg vol (10-day) 31.08M
Shares outstanding 5258.1M
Implied shares outstanding 6258.1M
Float 8257.33M
% held by insiders 10.08%
% held by institutions 195.57%
Shares short (13 Sept 2024) 44.34M
Short ratio (13 Sept 2024) 44.28
Short % of float (13 Sept 2024) 41.68%
Short % of shares outstanding (13 Sept 2024) 41.68%
Shares short (prior month 15 Aug 2024) 44.42M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 324 Aug 2000

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin -4.74%
Operating margin (ttm)35.34%

Management effectiveness

Return on assets (ttm)12.96%
Return on equity (ttm)-3.24%

Income statement

Revenue (ttm)10.34B
Revenue per share (ttm)40.08
Quarterly revenue growth (yoy)6.10%
Gross profit (ttm)N/A
EBITDA 4.39B
Net income avi to common (ttm)-489.9M
Diluted EPS (ttm)-1.99
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.8B
Total cash per share (mrq)22.45
Total debt (mrq)933.4M
Total debt/equity (mrq)6.32%
Current ratio (mrq)2.52
Book value per share (mrq)57.26

Cash flow statement

Operating cash flow (ttm)-944M
Levered free cash flow (ttm)2.89B